NanoViricides
NNVC
#10372
Rank
โ‚น3.37 B
Marketcap
โ‚น146.79
Share price
-5.00%
Change (1 day)
-0.06%
Change (1 year)

EPS for NanoViricides (NNVC)

EPS in 2026 (TTM): -โ‚น39.14

According to NanoViricides's latest financial reports the company's current EPS (TTM) is -โ‚น42.49. In 2025 the company made an earnings per share (EPS) of -โ‚น60.84 an increase over its 2024 EPS that were of -โ‚น67.60.

EPS history for NanoViricides from 2005 to 2026

Annual EPS

Year EPS Change
2026 (TTM)-โ‚น39.14-35.67%
2025-โ‚น60.84-10%
2024-โ‚น67.60-5.41%
2023-โ‚น71.465.71%
2022-โ‚น67.60-13.58%
2021-โ‚น78.22-66.11%
2020-โ‚น230.811.7%
2019-โ‚น226.95-10.98%
2018-โ‚น254.95-22.35%
2017-โ‚น328.35-10.53%
2016-โ‚น366.98375%
2015-โ‚น77.26-85.19%
2014-โ‚น521.4942.11%
2013-โ‚น366.9826.67%
2012-โ‚น289.72-6.25%
2011-โ‚น309.0314.28%
2010-โ‚น270.40100%
2009-โ‚น135.20-0%
2008-โ‚น135.20-33.33%
2007-โ‚น202.80-0%
2006-โ‚น202.804445.07%
2005-โ‚น4.46

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Gilead Sciences
GILD
โ‚น716.57-1,786.36%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
โ‚น345.24-912.47%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
โ‚น343.80-909.09%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
โ‚น375.31-983.25%๐Ÿ‡ฌ๐Ÿ‡ง UK
Novavax
NVAX
-โ‚น52.15 22.73%๐Ÿ‡บ๐Ÿ‡ธ USA
BioCryst Pharmaceuticals
BCRX
-โ‚น167.07 293.18%๐Ÿ‡บ๐Ÿ‡ธ USA